Malaria

Oxford’s malaria shot set for phase 3 test after ‘unprecedented’ 77% efficacy

  • by

Following the success of the coronavirus vaccine developed with AstraZeneca, Oxford University’s Jenner Institute has unveiled trial results showing its experimental malaria shot could be around 77% effective. There is a malaria vaccine on the market – GlaxoSmithKline’s Mosquirix – but this is only around… Read More »Oxford’s malaria shot set for phase 3 test after ‘unprecedented’ 77% efficacy